Etofylline nicotinate
Chemical compound
- C04AD04 (WHO)
- 2-(1,3-Dimethyl-2,6-dioxopurin-7-yl)ethyl pyridine-3-carboxylate
- 13425-39-3
- 83435
- 75285
- SN6D1V68DL
- DTXSID30158609
- Interactive image
- Cn1c2c(c(=O)n(c1=O)C)n(cn2)CCOC(=O)c3cccnc3
InChI
- InChI=1S/C15H15N5O4/c1-18-12-11(13(21)19(2)15(18)23)20(9-17-12)6-7-24-14(22)10-4-3-5-16-8-10/h3-5,8-9H,6-7H2,1-2H3
- Key:ZWIAODBBEZGVPY-UHFFFAOYSA-N
Etofylline nicotinate is a vasodilator.[1]
References
- ^ Vilar S, Quezada E, Alcaide C, Orallo F, Santana L, Uriarte E (9 March 2007). "Quantitative Structure Vasodilatory Activity Relationship – Synthesis and "In Silico" and "In Vitro" Evaluation of Resveratrol-Coumarin Hybrids". QSAR & Combinatorial Science. 26 (3): 317–332. doi:10.1002/qsar.200630006.
- v
- t
- e
Peripheral vasodilators (C04)
- Isoxsuprine
- Buphenine
- Bamethan
- Non-selective
- Selective α1-blockers
- Pentifylline
- Xantinol nicotinate
- Pentoxifylline
- Etofylline nicotinate
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e